Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma
Jittiporn Chaisaingmongkol, Anuradha Budhu, Hien Dang, et al.
Cancer Cell (2017) Vol. 32, Iss. 1, pp. 57-70.e3
Open Access | Times Cited: 368

Showing 26-50 of 368 citing articles:

Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin
Benjamin Ruf, Matthias Bruhns, Sepideh Babaei, et al.
Cell (2023) Vol. 186, Iss. 17, pp. 3686-3705.e32
Open Access | Times Cited: 77
Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinoma
Yun‐Fan Sun, Pin Wu, Zefan Zhang, et al.
Cancer Cell (2023) Vol. 42, Iss. 1, pp. 135-156.e17
Closed Access | Times Cited: 51
Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer
Hui Yang, Jinghui Cheng, Hao Zhuang, et al.
Cancer Cell (2024) Vol. 42, Iss. 4, pp. 535-551.e8
Open Access | Times Cited: 33
Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product
Avanish Mishra, Shih‐Bo Huang, Taronish D. Dubash, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Digestive cancers: mechanisms, therapeutics and management
Tianzuo Zhan, Johannes Betge, Nadine Schulte, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Active repression of cell fate plasticity by PROX1 safeguards hepatocyte identity and prevents liver tumorigenesis
Bryce Lim, Aryan Kamal, Borja Gomez Ramos, et al.
Nature Genetics (2025)
Open Access | Times Cited: 2
Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis
Jesús M. Bañales, Mercedes Iñarrairaegui, Ander Arbelaiz, et al.
Hepatology (2018) Vol. 70, Iss. 2, pp. 547-562
Open Access | Times Cited: 157
Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells
Germana Castelli, Elvira Pelosi, Ugo Testa
Cancers (2017) Vol. 9, Iss. 9, pp. 127-127
Open Access | Times Cited: 144
Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures
Aatur D. Singhi, Marina N. Nikiforova, Jennifer Chennat, et al.
Gut (2019) Vol. 69, Iss. 1, pp. 52-61
Open Access | Times Cited: 141
Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes
Lulu Sun, Yuqing Wang, Jin Cen, et al.
Nature Cell Biology (2019) Vol. 21, Iss. 8, pp. 1015-1026
Closed Access | Times Cited: 132
Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma
Chirag Nepal, Colm J. O’Rourke, Douglas V.N.P. Oliveira, et al.
Hepatology (2017) Vol. 68, Iss. 3, pp. 949-963
Open Access | Times Cited: 122
Desmoplastic Tumor Microenvironment and Immunotherapy in Cholangiocarcinoma
Dan Høgdall, Monika Lewińska, Jesper B. Andersen
Trends in cancer (2018) Vol. 4, Iss. 3, pp. 239-255
Closed Access | Times Cited: 111
Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine
Feihu Xie, Lejia Sun, Yuan Pang, et al.
Biomaterials (2020) Vol. 265, pp. 120416-120416
Closed Access | Times Cited: 107
Metabolomics and Multi-Omics Integration: A Survey of Computational Methods and Resources
Tara Eicher, Garrett Kinnebrew, Andrew Patt, et al.
Metabolites (2020) Vol. 10, Iss. 5, pp. 202-202
Open Access | Times Cited: 106
Diagnostic and prognostic biomarkers in cholangiocarcinoma
Rocı́o I.R. Macı́as, Miroslaw Kornek, Pedro M. Rodrigues, et al.
Liver International (2019) Vol. 39, Iss. S1, pp. 108-122
Open Access | Times Cited: 104
Lnc‐UCID Promotes G1/S Transition and Hepatoma Growth by Preventing DHX9‐Mediated CDK6 Down‐regulation
Yunlong Wang, Jinyu Liu, Jine Yang, et al.
Hepatology (2019) Vol. 70, Iss. 1, pp. 259-275
Open Access | Times Cited: 98
Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma
Benjamin Goeppert, Stephanie Roessler, Marcus Renner, et al.
British Journal of Cancer (2018) Vol. 120, Iss. 1, pp. 109-114
Open Access | Times Cited: 93
The genomic landscape of Mongolian hepatocellular carcinoma
Julián Candia, Enkhjargal Bayarsaikhan, Mayank Tandon, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 83
Integrative metabolomic characterisation identifies altered portal vein serum metabolome contributing to human hepatocellular carcinoma
Jinkai Liu, Wei Geng, Hanyong Sun, et al.
Gut (2021) Vol. 71, Iss. 6, pp. 1203-1213
Open Access | Times Cited: 83
Understanding tumour cell heterogeneity and its implication for immunotherapy in liver cancer using single-cell analysis
S. Heinrich, Amanda J. Craig, Lichun Ma, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 3, pp. 700-715
Closed Access | Times Cited: 75
Up-to-Date Pathologic Classification and Molecular Characteristics of Intrahepatic Cholangiocarcinoma
Taek Chung, Young Nyun Park
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 51
Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma
Amelia L. Parker, Elise D. Bowman, Adriana Zingone, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 43
Liver cancer heterogeneity modeled by in situ genome editing of hepatocytes
Mei Tang, Yang Zhao, Jianhui Zhao, et al.
Science Advances (2022) Vol. 8, Iss. 25
Open Access | Times Cited: 39
A multimodal atlas of tumour metabolism reveals the architecture of gene–metabolite covariation
Elisa Benedetti, Eric Minwei Liu, Cerise Tang, et al.
Nature Metabolism (2023) Vol. 5, Iss. 6, pp. 1029-1044
Open Access | Times Cited: 32
Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making
Renumathy Dhanasekaran, Hiroyuki Suzuki, L Lemaître, et al.
Hepatology (2023)
Closed Access | Times Cited: 25

Scroll to top